|
C13ORF38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.583200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.079400E-01 |
| Normal-vs-Stage2 |
6.560800E-01 |
| Normal-vs-Stage3 |
4.936400E-01 |
| Normal-vs-Stage4 |
4.836200E-02 |
| Stage1-vs-Stage2 |
4.191800E-01 |
| Stage1-vs-Stage3 |
2.130600E-01 |
| Stage1-vs-Stage4 |
3.275900E-02 |
| Stage2-vs-Stage3 |
9.417400E-01 |
| Stage2-vs-Stage4 |
7.871800E-02 |
| Stage3-vs-Stage4 |
7.539700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.172400E-01 |
| Normal-vs-AfricanAmerican |
4.425000E-01 |
| Normal-vs-Asian |
4.014000E-01 |
| Caucasian-vs-AfricanAmerican |
2.223800E-01 |
| Caucasian-vs-Asian |
4.345600E-01 |
| AfricanAmerican-vs-Asian |
2.142000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.550200E-01 |
| Normal-vs-Female |
6.568600E-01 |
| Male-vs-Female |
7.505200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.212000E-01 |
| Normal-vs-Extreme_Weight |
8.542300E-02 |
| Normal-vs-Obese |
6.358800E-01 |
| Normal-vs-Extreme_Obese |
2.266200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.750770E-01 |
| Normal_Weight-vs-Obese |
8.484800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.088000E-01 |
| Extreme_Weight-vs-Obese |
1.079410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.939880E-02 |
| Obese-vs-Extreme_Obese |
4.268000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.301800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.308000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.932600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.082400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.147800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.556200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.093200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.822400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.122800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.474400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.827500E-02 |
| Normal-VS-Type2 PRCC |
4.050100E-02 |
| Normal-VS-KIRP CIMP |
3.392400E-01 |
| Normal-VS-Unclassified PRCC |
9.678100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.576800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.468100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.059770E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.649200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.420800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.279600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.750600E-01 |
| Normal-vs-N1 |
1.479640E-02 |
| Normal-vs-N2 |
7.718300E-02 |
| N0-vs-N1 |
4.346000E-02 |
| N0-vs-N2 |
3.794000E-01 |
| N1-vs-N2 |
9.709600E-02 |
|
|
